Selective Inhibitors of Zinc-Dependent Histone Deacetylases. Therapeutic Targets Relevant to Cancer

E-ISSN： 1873-4286|21|11|1472-1502

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.11, 2015-02, pp. : 1472-1502

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of NAD+ Dependent Histone Deacetylases (Sirtuins)

Current Pharmaceutical Design, Vol. 14, Iss. 6, 2008-02 ,pp. : 562-573

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment

Current Clinical Pharmacology, Vol. 5, Iss. 3, 2010-08 ,pp. : 196-208

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Studies on the Histone Deacetylases and the Design of Selective Histone Deacetylase Inhibitors

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 3, 2009-02 ,pp. : 241-256

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases as Targets for Multiple Diseases

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 7, 2013-06 ,pp. : 1005-1026

Bentham Science Publishers

Access to resources Recommend Favorite